JPRN-UMIN000015698已完成未知
Phase II trial of ethinylestradiol for aromatase inhibitor-resistant postmenopausal advanced/recurrent breast cancer patients - AIR-EE2
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Inflammatory breast cancer 2. Any malignant neoplasms 3. Severe cardiac disease(e.g. myocardial infarction, valvular disease, heart failure) 4. Liver cirrhosis 5. Thrombosis 6. Judged inappropriate by physicians
研究者
相似试验
招募中
2 期
Pre-surgical aromatase inhibitor combined with non-steroidal anti inflammatory drug treatment in breast cancerpost menopausal breast cancerCancer - BreastACTRN12614000507684niversity of otago100
终止
2 期
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast CancerBreast CancerNCT00498901University of Washington1
已完成
1 期
Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female SubjectsHealthyNCT02080468Aegerion Pharmaceuticals, Inc.32
进行中（未招募）
不适用
Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological neoplasmsWomen with oestrogen receptor and/or progesterone receptor positive (ER/PR+ve) potentially hormone responsive recurrent or metastatic gynaecological cancer including selected patients with epithelial ovarian cancer, endometrial cancers, miscellaneous sarcomas and sex cord stromal tumours of the ovaryEUCTR2011-003192-11-BEniversity of Sydney
招募中
2 期
Vaginal Oestriol to prevent vaginal stenosis (VESPA).ACTRN12621001366842Western Sydney Local Health District45